If I'm right that the panel you've pictured is that, then everything is explained. A terminal for the VDU (visual display unit), parallel input and output connections, 3 DACs and 2 ADCs (for two eyes).
October 31, 2026 at 7:40 PM
If I'm right that the panel you've pictured is that, then everything is explained. A terminal for the VDU (visual display unit), parallel input and output connections, 3 DACs and 2 ADCs (for two eyes).
ADCS warns against automatic child-in-need status for kinship children
www.cypnow.co.uk/content/news...
www.cypnow.co.uk/content/news...
ADCS warns against automatic child-in-need status for kinship children - CYP Now
Automatically classifying all children in kinship care as children in need could trigger unnecessary assessments and statutory scrutiny of stable family arra...
www.cypnow.co.uk
November 3, 2026 at 5:16 PM
ADCS warns against automatic child-in-need status for kinship children
www.cypnow.co.uk/content/news...
www.cypnow.co.uk/content/news...
I have not been able to practice Sett in two days bc apparently every person on KR server wants to play top lane so I keep getting autofilled support with the goofiest rando adcs HELP
November 1, 2026 at 5:20 AM
I have not been able to practice Sett in two days bc apparently every person on KR server wants to play top lane so I keep getting autofilled support with the goofiest rando adcs HELP
The output was fed into a light meter which produced a voltage output that was a ~linear measure of eye position. To capture that so as to know where to set the display, you needed an ADC. This was a real pain. ADCs worked by using a DAC and searching for a voltage match to the source. Very slow.
October 31, 2026 at 7:40 PM
The output was fed into a light meter which produced a voltage output that was a ~linear measure of eye position. To capture that so as to know where to set the display, you needed an ADC. This was a real pain. ADCs worked by using a DAC and searching for a voltage match to the source. Very slow.
Attackers are using Teams calls to impersonate IT, gain remote access, and abuse enterprise certificates. #CyberSecurity #MicrosoftTeams #ADCS #RemoteAccess #CertificateAbuse https://thedailytechfeed.com/attackers-exploit-microsoft-teams-for-remote-access-through-help-desk-masquerade/
November 2, 2026 at 1:00 PM
Attackers are using Teams calls to impersonate IT, gain remote access, and abuse enterprise certificates. #CyberSecurity #MicrosoftTeams #ADCS #RemoteAccess #CertificateAbuse https://thedailytechfeed.com/attackers-exploit-microsoft-teams-for-remote-access-through-help-desk-masquerade/
Attackers posing as Teams IT support abused AD CS (ESC1/ESC8) to hijack privileged identities. #Cybersecurity #ADCS #MicrosoftTeams #IdentitySecurity #ESC1 #ESC8 #PetitPotam https://thedailytechfeed.com/attackers-masquerade-as-microsoft-teams-it-support-abuse-ad-cs-to-steal-data/
November 2, 2026 at 11:30 AM
Attackers posing as Teams IT support abused AD CS (ESC1/ESC8) to hijack privileged identities. #Cybersecurity #ADCS #MicrosoftTeams #IdentitySecurity #ESC1 #ESC8 #PetitPotam https://thedailytechfeed.com/attackers-masquerade-as-microsoft-teams-it-support-abuse-ad-cs-to-steal-data/
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social shared from #JADPROLive2026 how their team selects patients for ADCs and monitors for lung, nerve, and heart toxicity. #BreastCancerAwareness
Read more in Oncology Nursing News: bit.ly/4iatkCr
Read more in Oncology Nursing News: bit.ly/4iatkCr
What Oncology Nurses Need to Know About ADCs in Breast Cancer | Oncology Nursing News
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
bit.ly
October 28, 2026 at 6:30 PM
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social shared from #JADPROLive2026 how their team selects patients for ADCs and monitors for lung, nerve, and heart toxicity. #BreastCancerAwareness
Read more in Oncology Nursing News: bit.ly/4iatkCr
Read more in Oncology Nursing News: bit.ly/4iatkCr
I've been watching $MRK; Merck pivots with sac-TMT ADCs and Intismeran adjuvant efficacy but Keytruda LOE, payer pressure and biosimilars risk need hard analysi. Buy15%
November 1, 2026 at 12:03 PM
I've been watching $MRK; Merck pivots with sac-TMT ADCs and Intismeran adjuvant efficacy but Keytruda LOE, payer pressure and biosimilars risk need hard analysi. Buy15%
US20260325667A1) discloses TF-targeted ADCs using branched pyridazine-pyrrolo linkers to deliver ≥2 drugs per coupling unit, enabling high DAR with fewer antibody modifications. Relevant to Exelixis’ XB371, although direct clinical correspondence remains unconfirmed.
November 3, 2026 at 6:34 AM
US20260325667A1) discloses TF-targeted ADCs using branched pyridazine-pyrrolo linkers to deliver ≥2 drugs per coupling unit, enabling high DAR with fewer antibody modifications. Relevant to Exelixis’ XB371, although direct clinical correspondence remains unconfirmed.
Discover what's new in radioligand therapeutics, ADCs, immunotherapy and radiation therapy at #ESMOGUAsia27.
⏰ Early registration closes 11 Nov 2026
📍 Hong Kong SAR, China | 15-17 Jan 2027
👉 https://ow.ly/Yvtl5101Zhb
#GUOncology #ESMOMeetings
⏰ Early registration closes 11 Nov 2026
📍 Hong Kong SAR, China | 15-17 Jan 2027
👉 https://ow.ly/Yvtl5101Zhb
#GUOncology #ESMOMeetings
November 3, 2026 at 6:00 AM
Discover what's new in radioligand therapeutics, ADCs, immunotherapy and radiation therapy at #ESMOGUAsia27.
⏰ Early registration closes 11 Nov 2026
📍 Hong Kong SAR, China | 15-17 Jan 2027
👉 https://ow.ly/Yvtl5101Zhb
#GUOncology #ESMOMeetings
⏰ Early registration closes 11 Nov 2026
📍 Hong Kong SAR, China | 15-17 Jan 2027
👉 https://ow.ly/Yvtl5101Zhb
#GUOncology #ESMOMeetings
THE CONVERSION BOTTLENECK
Light may compute fast, but data still has to enter and leave the optical domain.
Discover why DACs, ADCs, modulation, and detection can limit system performance. True efficiency requires a seamless co-design.
#PhotonicComputing #Semiconductors #TechInnovation #AIHardware
Light may compute fast, but data still has to enter and leave the optical domain.
Discover why DACs, ADCs, modulation, and detection can limit system performance. True efficiency requires a seamless co-design.
#PhotonicComputing #Semiconductors #TechInnovation #AIHardware
November 3, 2026 at 9:16 PM
THE CONVERSION BOTTLENECK
Light may compute fast, but data still has to enter and leave the optical domain.
Discover why DACs, ADCs, modulation, and detection can limit system performance. True efficiency requires a seamless co-design.
#PhotonicComputing #Semiconductors #TechInnovation #AIHardware
Light may compute fast, but data still has to enter and leave the optical domain.
Discover why DACs, ADCs, modulation, and detection can limit system performance. True efficiency requires a seamless co-design.
#PhotonicComputing #Semiconductors #TechInnovation #AIHardware
i had to manipulate 32 tiny little resistors and capacitors to mod these ADCs because they come from the factory shitty apparently. i can not exactly recommend hand soldering 32 tiny little smd resistors and capacitors hope it works
October 30, 2026 at 4:55 PM
i had to manipulate 32 tiny little resistors and capacitors to mod these ADCs because they come from the factory shitty apparently. i can not exactly recommend hand soldering 32 tiny little smd resistors and capacitors hope it works
#ESMO26: Novel targeted treatments, including antibody–drug conjugates (#ADCs) and bispecific antibodies, show good responses in #immunotherapy-resistant #melanoma, although toxicity and cost are potential concerns.
Read more:
🔗 https://ow.ly/fv2I5100nzS
#InsightsbyESMO
Read more:
🔗 https://ow.ly/fv2I5100nzS
#InsightsbyESMO
October 27, 2026 at 3:30 PM
#ESMO26: Novel targeted treatments, including antibody–drug conjugates (#ADCs) and bispecific antibodies, show good responses in #immunotherapy-resistant #melanoma, although toxicity and cost are potential concerns.
Read more:
🔗 https://ow.ly/fv2I5100nzS
#InsightsbyESMO
Read more:
🔗 https://ow.ly/fv2I5100nzS
#InsightsbyESMO
Watching $MRK: Merck oncology stead; sac-TMT ADCs offset Keytruda LOE. 15%. analysi. https://endpoints.news/rd-chief-dean-li-says-merck-outflanked-rivals-with-its-sac-tmt-cancer-program/
October 30, 2026 at 4:09 PM
Watching $MRK: Merck oncology stead; sac-TMT ADCs offset Keytruda LOE. 15%. analysi. https://endpoints.news/rd-chief-dean-li-says-merck-outflanked-rivals-with-its-sac-tmt-cancer-program/
WO2026219324A1 discloses novel #NMT1/2-inhibitor payloads and ADCs, including trastuzumab constructs at DAR4/8. Cell assays and a JIMT-1 xenograft support preclinical evaluation; therapeutic-window advantages over #TOP1 ADCs remain unproven.
October 28, 2026 at 9:44 AM
WO2026219324A1 discloses novel #NMT1/2-inhibitor payloads and ADCs, including trastuzumab constructs at DAR4/8. Cell assays and a JIMT-1 xenograft support preclinical evaluation; therapeutic-window advantages over #TOP1 ADCs remain unproven.
🧬 See how tiered mass spec strategies can guide lead advancement for mAbs, bispecifics & ADCs, from candidate triage to final lead assessment.
📅 Nov 3 | 2 PM GMT / 3 PM CET
👉 Register:
www.labroots.com/ms/webinar/m...
📅 Nov 3 | 2 PM GMT / 3 PM CET
👉 Register:
www.labroots.com/ms/webinar/m...
October 30, 2026 at 4:05 PM
🧬 See how tiered mass spec strategies can guide lead advancement for mAbs, bispecifics & ADCs, from candidate triage to final lead assessment.
📅 Nov 3 | 2 PM GMT / 3 PM CET
👉 Register:
www.labroots.com/ms/webinar/m...
📅 Nov 3 | 2 PM GMT / 3 PM CET
👉 Register:
www.labroots.com/ms/webinar/m...
What’s new in lung cancer treatment? Join @LauraAlderMD at Lung Cancer OncTalk 2026 to explore ADCs, bispecific antibodies, and emerging therapies.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-l...
#LungCancer #NSCLC #ADCsBispecifics
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-l...
#LungCancer #NSCLC #ADCsBispecifics
October 29, 2026 at 6:08 PM
What’s new in lung cancer treatment? Join @LauraAlderMD at Lung Cancer OncTalk 2026 to explore ADCs, bispecific antibodies, and emerging therapies.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-l...
#LungCancer #NSCLC #ADCsBispecifics
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-l...
#LungCancer #NSCLC #ADCsBispecifics
"The international study found about a third of experiencers - 34% - had sentient-only ADCs. Of those, 68% said they could tell where in space the person was located relative to them & 3/4 thought the loved ones were trying to send them a message by their presence."
www.catholic.com/magazine/onl...
www.catholic.com/magazine/onl...
When People Hear from the Dead
After-death communications are a real phenomenon. But what are they like, and how do they work? How do people perceive them?
www.catholic.com
November 3, 2026 at 11:53 PM
"The international study found about a third of experiencers - 34% - had sentient-only ADCs. Of those, 68% said they could tell where in space the person was located relative to them & 3/4 thought the loved ones were trying to send them a message by their presence."
www.catholic.com/magazine/onl...
www.catholic.com/magazine/onl...
Oncology’s evolving landscape: ADCs, immunotherapies & emerging treatments are extending life but presenting new ocular challenges.
Oncology-ophthalmology collaboration must keep pace to recognise adverse events early and protect sight.🔗
#Oncology #Ophthalmology
Oncology-ophthalmology collaboration must keep pace to recognise adverse events early and protect sight.🔗
#Oncology #Ophthalmology
October 27, 2026 at 10:22 AM
Oncology’s evolving landscape: ADCs, immunotherapies & emerging treatments are extending life but presenting new ocular challenges.
Oncology-ophthalmology collaboration must keep pace to recognise adverse events early and protect sight.🔗
#Oncology #Ophthalmology
Oncology-ophthalmology collaboration must keep pace to recognise adverse events early and protect sight.🔗
#Oncology #Ophthalmology
why were the adcs on a path of bloody war holy shit
October 25, 2026 at 8:31 PM
why were the adcs on a path of bloody war holy shit
ADCs took center stage in lung cancer at #ESMO26. Read the recap of the top LBAs: www.targetedonc.com/view/esmo-20...
ESMO 2026: ADCs and New Combinations Advance Lung Cancer Care | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
ADCs improved on chemotherapy-based regimens in PD-L1–negative and EGFR-mutated NSCLC, while chemotherapy plus pembrolizumab and pumitamig plus docetaxel showed activity in PD-L1–high and post-chemoim...
www.targetedonc.com
October 27, 2026 at 3:22 PM
ADCs took center stage in lung cancer at #ESMO26. Read the recap of the top LBAs: www.targetedonc.com/view/esmo-20...
This has to be the craziest supportal kombat i've ever seen what the fuck were the ADCs doing all lane
October 25, 2026 at 10:20 PM
This has to be the craziest supportal kombat i've ever seen what the fuck were the ADCs doing all lane
So good to see supportive care on a highlights stage. With ADCs and bispecifics keeping patients on therapy longer, anticipating toxicity early is part of the regimen, not an afterthought.
October 28, 2026 at 12:00 AM
So good to see supportive care on a highlights stage. With ADCs and bispecifics keeping patients on therapy longer, anticipating toxicity early is part of the regimen, not an afterthought.
Hediyeh Soltanizadeh, Ardavan Rahimian: Coordinated and Uncoordinated Channel Tracking for High-Rate IoT in Distributed Massive MIMO With Low-Resolution ADCs https://arxiv.org/abs/2610.37508 https://arxiv.org/pdf/2610.37508 https://arxiv.org/html/2610.37508
October 28, 2026 at 6:46 AM
Hediyeh Soltanizadeh, Ardavan Rahimian: Coordinated and Uncoordinated Channel Tracking for High-Rate IoT in Distributed Massive MIMO With Low-Resolution ADCs https://arxiv.org/abs/2610.37508 https://arxiv.org/pdf/2610.37508 https://arxiv.org/html/2610.37508
amo as duas kkkkkk minhas adcs favoritas junto com a ashe
October 25, 2026 at 3:02 AM
amo as duas kkkkkk minhas adcs favoritas junto com a ashe